Journal Scans
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
Quality of Response to Transplantation Influences Survival
JJ Lahuerta, MV Mateos, J Martínez-López, L Rosiñol, A Sureda, J de la Rubia, J García-Laraña, R Martínez-Martínez, MT Hernández-García, D Carrera, J Besalduch, F de Arriba, JM Ribera, L Escoda B Hernández-Ruiz, J García-Frade, C Rivas-González, A Alegre, J Bladé, JF San Miguel
20081110
2008 Dec 10
J Clin Oncol
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
J Clin Oncol. 2008 Dec 10;26(35):5775-5782, JJ Lahuerta, MV Mateos, J Martínez-López, L Rosiñol, A Sureda, J de la Rubia, J García-Laraña, R Martínez-Martínez, MT Hernández-García, D Carrera, J Besalduch, F de Arriba, JM Ribera, L Escoda B Hernández-Ruiz, J García-Frade, C Rivas-González, A Alegre, J Bladé, JF San Miguel
ABSTRACT
Editors' Choice
Results of a phase I trial showed marked activity of an oral PARP inhibitor in BRCA1/2-mutated tumors.
